Katherine A. High

Insider Reports History

Entity
Individual
Location
3737 Market Street, Suite 1300, Philadelphia, PA
Signature
/s/ Elizabeth Feeney, Attorney-In-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Katherine A. High:

Stock Role Class Num Shares Value Price $ Report Date Ownership
INCYTE CORP Director Common Stock 10.8K $649K $59.94 Jun 12, 2024 Direct
CRISPR Therapeutics AG Director Stock Option (Right to Buy) 13K May 30, 2024 Direct
INCYTE CORP Director Non Qualfied Stock Option (right to buy) 12.5K Jun 12, 2024 Direct
INCYTE CORP Director Non-Qualified Stock Option (right to buy) 11.3K Jun 14, 2023 Direct

Insider Reports Filed by Katherine A. High

Symbol Company Period Transactions Value $ Form Type Date Filed Role
INCY INCYTE CORP Jun 12, 2024 2 $0 4 Jun 14, 2024 Director
CRSP CRISPR Therapeutics AG May 30, 2024 1 $0 4 May 31, 2024 Director
INCY INCYTE CORP Jun 14, 2023 2 $0 4 Jun 16, 2023 Director
CRSP CRISPR Therapeutics AG Jun 8, 2023 1 $0 4 Jun 9, 2023 Director
INCY INCYTE CORP Jun 15, 2022 2 $0 4 Jun 17, 2022 Director
CRSP CRISPR Therapeutics AG Jun 9, 2022 1 $0 4 Jun 10, 2022 Director
CRSP CRISPR Therapeutics AG Jun 10, 2021 1 $0 4 Jun 14, 2021 Director
INCY INCYTE CORP May 26, 2021 2 $0 4 May 28, 2021 Director